12131 related articles for article (PubMed ID: 12068387)
1. Histamine in cancer immunotherapy: a preclinical background.
Hellstrand K
Semin Oncol; 2002 Jun; 29(3 Suppl 7):35-40. PubMed ID: 12068387
[TBL] [Abstract][Full Text] [Related]
2. Histamine as an adjunct to immunotherapy.
Naredi P
Semin Oncol; 2002 Jun; 29(3 Suppl 7):31-4. PubMed ID: 12068386
[TBL] [Abstract][Full Text] [Related]
3. Cancer immunotherapy with natural killer cells.
Herberman RB
Semin Oncol; 2002 Jun; 29(3 Suppl 7):27-30. PubMed ID: 12068385
[TBL] [Abstract][Full Text] [Related]
4. Histamine and cytokine therapy.
Hellstrand K; Hermodsson S; Naredi P; Mellqvist UH; Brune M
Acta Oncol; 1998; 37(4):347-53. PubMed ID: 9743456
[TBL] [Abstract][Full Text] [Related]
5. Histamine: a novel approach to cancer immunotherapy.
Hellstrand K; Brune M; Naredi P; Mellqvist UH; Hansson M; Gehlsen KR; Hermodsson S
Cancer Invest; 2000; 18(4):347-55. PubMed ID: 10808371
[TBL] [Abstract][Full Text] [Related]
6. New applications of cancer immunotherapy.
Agarwala SS
Semin Oncol; 2002 Jun; 29(3 Suppl 7):1-4. PubMed ID: 12068381
[No Abstract] [Full Text] [Related]
7. Histamine dihydrochloride and interleukin-2 in the treatment of acute myeloid leukemia.
Stadtmauer EA
Semin Oncol; 2002 Jun; 29(3 Suppl 7):47-51. PubMed ID: 12068389
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic options in the management of renal cell carcinoma.
Glaspy JA
Semin Oncol; 2002 Jun; 29(3 Suppl 7):41-6. PubMed ID: 12068388
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant histamine in cancer immunotherapy.
Hellstrand K; Hansson M; Hermodsson S
Semin Cancer Biol; 2000 Feb; 10(1):29-39. PubMed ID: 10888269
[TBL] [Abstract][Full Text] [Related]
10. Immune response in blood and tumour tissue in patients with metastatic malignant melanoma treated with IL-2, IFN alpha and histamine dihydrochloride.
Jørkov AS; Donskov F; Steiniche T; Ternesten-Bratel A; Naredi P; Hellstrand K; Hokland M
Anticancer Res; 2003; 23(1B):537-42. PubMed ID: 12680142
[TBL] [Abstract][Full Text] [Related]
11. NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites.
Brune M; Hansson M; Mellqvist UH; Hermodsson S; Hellstrand K
Eur J Haematol; 1996 Oct; 57(4):312-9. PubMed ID: 8982295
[TBL] [Abstract][Full Text] [Related]
12. Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).
Asemissen AM; Scheibenbogen C; Letsch A; Hellstrand K; Thorén F; Gehlsen K; Schmittel A; Thiel E; Keilholz U
Clin Cancer Res; 2005 Jan; 11(1):290-7. PubMed ID: 15671558
[TBL] [Abstract][Full Text] [Related]
13. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activation of human natural killer cell cytotoxicity by histamine and interleukin-2.
Hellstrand K; Hermodsson S
Int Arch Allergy Appl Immunol; 1990; 92(4):379-89. PubMed ID: 2150668
[TBL] [Abstract][Full Text] [Related]
15. Alleviating oxidative stress in cancer immunotherapy: a role for histamine?
Hellstrand K; Brune M; Dahlgren C; Hansson M; Hermodsson S; Lindnér P; Mellqvist UH; Naredi P
Med Oncol; 2000 Nov; 17(4):258-69. PubMed ID: 11114704
[TBL] [Abstract][Full Text] [Related]
16. Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites.
Hellstrand K; Asea A; Dahlgren C; Hermodsson S
J Immunol; 1994 Dec; 153(11):4940-7. PubMed ID: 7963557
[TBL] [Abstract][Full Text] [Related]
17. Histamine in cancer immunotherapy.
Hellstrand K; Hermodsson S; Brune M; Naredi P; Carneskog J; Mellqvist UH
Scand J Clin Lab Invest; 1997 May; 57(3):193-202. PubMed ID: 9238754
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine.
Mellqvist UH; Hansson M; Brune M; Dahlgren C; Hermodsson S; Hellstrand K
Blood; 2000 Sep; 96(5):1961-8. PubMed ID: 10961901
[TBL] [Abstract][Full Text] [Related]
19. Histamine protects T cells and natural killer cells against oxidative stress.
Hansson M; Hermodsson S; Brune M; Mellqvist UH; Naredi P; Betten A; Gehlsen KR; Hellstrand K
J Interferon Cytokine Res; 1999 Oct; 19(10):1135-44. PubMed ID: 10547153
[TBL] [Abstract][Full Text] [Related]
20. Cell-to-cell mediated inhibition of natural killer cell proliferation by monocytes and its regulation by histamine H2-receptors.
Hellstrand K; Hermodsson S
Scand J Immunol; 1991 Dec; 34(6):741-52. PubMed ID: 1836274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
